LTRN•benzinga•
Lantern Pharma Doses First Patient In Japan For Expansion Cohort In Phase 2 HARMONIC Clinical Trial Of LP-300 In Never-Smoker NSCLC Patients
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 19, 2024 by benzinga